Mastanzade, M. G. Et Al. 2021. Non-disease-originated leukocyte subset chimerism and the clinical outcome in hematopoetic stem cell transplantation. EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51 , 367.

Mastanzade, M. G., BEŞIŞIK, S., ÖGRET, Y., OĞUZ, F., Hindilerden, I. Y., & NALÇACI, M., (2021). Non-disease-originated leukocyte subset chimerism and the clinical outcome in hematopoetic stem cell transplantation. EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, 367.

Mastanzade, Metban Et Al. "Non-disease-originated leukocyte subset chimerism and the clinical outcome in hematopoetic stem cell transplantation," EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, 367, 2021

Mastanzade, Metban G. Et Al. "Non-disease-originated leukocyte subset chimerism and the clinical outcome in hematopoetic stem cell transplantation." EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, pp.367, 2021

Mastanzade, M. G. Et Al. (2021) . "Non-disease-originated leukocyte subset chimerism and the clinical outcome in hematopoetic stem cell transplantation." EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, p.367.

@article{article, author={Metban Guzel Mastanzade Et Al. }, title={Non-disease-originated leukocyte subset chimerism and the clinical outcome in hematopoetic stem cell transplantation}, journal={EUROPEAN JOURNAL OF IMMUNOLOGY}, year=2021, pages={367} }